(Q38134785)

29 August 2017

title

Blau syndrome-associated uveitis and the NOD2 gene (English)

1 reference

29 August 2017

1 reference

Parvathy Pillai

1 reference

29 August 2017

Lucia Sobrin

series ordinal

1 reference

29 August 2017

language of work or name

English

0 references

publication date

6 September 2013

1 reference

Seminars in Ophthalmology

29 August 2017

published in

1 reference

29 August 2017

1 reference

29 August 2017

issue

5-6

1 reference

29 August 2017

page(s)

327-332

1 reference

Familial granulomatous synovitis, uveitis, and cranial neuropathies

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Sinus of valsalva aneurysm in Blau's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

NOD2-associated pediatric granulomatous arthritis, an expanding phenotype: study of an international registry and a national cohort in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Multifocal choroiditis in patients with familial juvenile systemic granulomatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

CARD15 mutations in Blau syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Incomplete penetrance of the NOD2 E383K substitution among members of a pediatric granulomatous arthritis pedigree.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Blau syndrome associated with a CARD15/NOD2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

NOD2 and Crohn's disease: loss or gain of function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Blau syndrome, clinical and genetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

With a mere nod, uveitis enters a new era

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Human endothelial cells express NOD2/CARD15 and increase IL-6 secretion in response to muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Activation of NOD2 in vivo induces IL-1beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Meta-analysis of NOD2/CARD15 polymorphisms with psoriasis and psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

NOD-LRR proteins: role in host-microbial interactions and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

21 January 2018

Blau syndrome revisited.

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08820538.2013.825285

10.3109/08820538.2013.825285

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference